HIMS

Hims Stock (HIMS) Outlook for 2026: Latest News, Canada Expansion, Buyback and Price Targets as of December 6, 2025

Hims & Hers Health (NYSE: HIMS) is back in the spotlight after a new $250 million buyback, expansion into Canada, and fresh acquisitions in lab testing and blood diagnostics. Here’s a comprehensive look at HIMS stock price, latest news, GLP‑1

6 December 2025

Hims & Hers Health (HIMS) Stock Today: Canada Expansion, Labs, GLP‑1 Growth and Fresh “Strong Buy” Call – Price, News & Forecast as of December 5, 2025

Hims & Hers Health, Inc. (NYSE: HIMS) is back in the market spotlight. As of early December 5, 2025, the telehealth company’s stock is trading around $40 per share, up sharply from recent lows but still far below its 52‑week

5 December 2025

Company Analysis · Financial Forecasts · Health Companies · Investment News · NYSE:HIMS · Stock Market

Hims & Hers (HIMS) Stock Jumps on Canada Launch and YourBio Deal: Latest News, Forecasts and Analysis for December 4, 2025

Hims & Hers Health, Inc. (NYSE: HIMS) is back in the spotlight. In Thursday’s session on December 4, 2025, the telehealth stock climbed roughly 5–8%, trading around $40 and valuing the company at about $12.8 billion, after a flurry of

4 December 2025

Company News · Financial Forecasts · Health Tech · Investment Analysis · NYSE:HIMS · Stock Market

Hims & Hers Health (HIMS) Stock Jumps on Policy Tailwinds and Buyback Momentum — November 24, 2025

Hims & Hers Health Inc. (NYSE: HIMS) ended Monday’s U.S. session sharply higher, extending a volatile but strongly positive year for the fast‑growing telehealth platform. Below is a news-style, SEO-optimized breakdown of Hims & Hers Health (HIMS) stock today (24.11.2025),

24 November 2025

Company Analysis · Financial News · Health Industry · Investment Strategies · NYSE:HIMS · Stock Market

Hims & Hers Health (HIMS) Stock Today, November 23, 2025: Price, Buyback and GLP‑1 Risks

Hims & Hers Health (NYSE: HIMS) heads into the new week as one of the market’s most closely watched telehealth and weight‑loss plays — but also one of its most volatile. After Friday’s session (21 November 2025), HIMS closed at

23 November 2025

Financial Analysis · GLP-1 Drugs · Healthcare Stocks · Investing · Stock Market

Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

HIMS Stock Today (November 18, 2025): Buyback, GLP‑1 Price War and What It Means for Hims & Hers Investors

On Tuesday, November 18, 2025, Hims & Hers Health (NYSE: HIMS) is trading in the shadow of a sharp sell‑off, a fresh $250 million share repurchase authorization, and escalating price competition in the weight‑loss drug market. Together, these forces are

18 November 2025

Buyback · GLP‑1 · Health Tech · Investor News · NYSE:HIMS · Stocks

Hims & Hers (HIMS) Stock Soars on Subscriber Surge and GLP-1 Deal Buzz – Nov 2025 Update

Current Stock Price (Nov 3, 2025) Hims & Hers Health’s stock (NYSE: HIMS) closed on Nov 3, 2025 at $44.39, down about 2.3% for the day stockanalysis.com. This modest dip came amid a broader mixed market and ahead of the

4 November 2025

Company News · Financial Analysis · Healthcare · Investing · NYSE:HIMS · Stock Market